Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Return on Invested Capital: 2012-2025

Historic Return on Invested Capital for Myriad Genetics (MYGN) over the last 12 years, with Sep 2025 value amounting to -0.84%.

  • Myriad Genetics' Return on Invested Capital fell 69.00% to -0.84% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.84%, marking a year-over-year decrease of 69.00%. This contributed to the annual value of -0.12% for FY2022, which is 3.00% down from last year.
  • Per Myriad Genetics' latest filing, its Return on Invested Capital stood at -0.84% for Q3 2025, which was down 30.15% from -0.65% recorded in Q2 2025.
  • Over the past 5 years, Myriad Genetics' Return on Invested Capital peaked at -0.04% during Q1 2022, and registered a low of -0.84% during Q3 2025.
  • Over the past 3 years, Myriad Genetics' median Return on Invested Capital value was -0.26% (recorded in 2024), while the average stood at -0.35%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first climbed by 20bps in 2024, then slumped by 69bps in 2025.
  • Over the past 5 years, Myriad Genetics' Return on Invested Capital (Quarterly) stood at -0.09% in 2021, then fell by 3bps to -0.12% in 2022, then fell by 20bps to -0.32% in 2023, then increased by 20bps to -0.15% in 2024, then tumbled by 69bps to -0.84% in 2025.
  • Its last three reported values are -0.84% in Q3 2025, -0.65% for Q2 2025, and -0.13% during Q1 2025.